Clinical trials
Bronchiolitis Obliterans Syndrome trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 5 |
| 2025 | 4 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 34 |
| Recruiting | 13 |
| Active, not recruiting | 7 |
| Terminated | 6 |
| Unknown status | 4 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 4 |
| Boston Scientific Corporation | 2 |
| University of Alabama at Birmingham | 2 |
| University of Miami | 2 |
| University of Texas Southwestern Medical Center | 2 |
| University of Utah | 2 |
| Vanderbilt University Medical Center | 2 |
| Abbott Medical Devices | 1 |
| Arteriocyte, Inc. | 1 |
| Austin Speech Labs | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bronchiolitis Obliterans Syndrome | 65 |
| Pain | 10 |
| Low Back Pain | 9 |
| Migraine Disorders | 5 |
| Stroke | 5 |
| Headache | 4 |
| Spinal Cord Injuries | 4 |
| Back Pain | 2 |
| Brain Injuries | 2 |
| Brain Injuries, Traumatic | 2 |
Trials
Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.